Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Novel rapid acoustic pulse device shows promise for treating cellulite

Key clinical point: A single rapid acoustic pulse treatment session corresponded to a 32.5% reduction in cellulite.
Major finding: Based on the Cellulite Severity Scale scores, 87% of the study subjects had some improvement of their cellulite after a single RAP treatment.
Study details: A multicenter trial of 62 female patients who were treated with a single, rapid acoustic pulse treatment.
Disclosures: Soliton sponsored the trial. Dr. Tanzi disclosed that she is either a consultant for or is a member of the scientific advisory board for Allergan/Coolsculpting, Beiersdorf, Cutera, Merz/Ulthera, Pulse Biosciences, Sciton, Soliton, Solta, and Syneron/Candela.


Tanzi E et al. AAD 20, late-breaking abstract.